In addition, Sen et al. used scRNA-seq technology to investigate the effect of combining CAR-T-cells with stimulator of interferon genes (STING) DMXAA/cGAMP in a breast cancer mouse model. This evidence concerns the gene STING1 and breast carcinoma.